REQUEST A DEMO
Total
USD $0.00
Search more companies

Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Exir Pharmaceutical Company Public Joint Stock Profile Updated: July 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2026 Available in: English Download a sample report

Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) is based in Iran. The head office is in Tehran. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on September 08, 1985. The total number of employees is currently 983 (2026). In Q12027, the company reported a net sales revenue increase of 157.25%. Over the same period, its total assets grew by 32.79%. In 2027, Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co)’s net profit margin increased by 15.32%.

Legal Address
18 Km Of Tehran-Karaj Special Road, Darupakhsh Street, Door No. 2 (Door Of The Houses) Of The Pharmaceutical Factor
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) report to view the information.

Website: http://www.exir.co.ir

Basic Information
Total Employees:
Purchase the Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) report to view the information.
Outstanding Shares:
Purchase the Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) report to view the information.
Financial Auditors:
Purchase the Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) report to view the information.
Incorporation Date:
September 08, 1985
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
81.16%
Purchase this report to view the information.
52.81%
Purchase this report to view the information.
33.96%
Company Performance
Financial values in the chart are available after Exir Pharmaceutical Company Public Joint Stock (Exir Pharmaceutical Co) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
157.25%
Total Operating Revenue
157.22%
Operating Profit
271.95%
EBITDA
267.31%
Net Profit/Loss for the Period
340.43%
Total Assets
32.79%
Total Equity
187.62%
Operating Profit Margin
16.06%
Net Profit Margin
15.32%
Return on Equity (ROE)
11.08%
Debt / Equity
-83.99%
Quick Ratio
0.71%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?